Similar articles

• [Treatment of cardiac and cerebrovascular insufficiency with Card-Cosaldon. Result of a field study].

  Koeppen G, Schmidt-Modrow G. Koeppen G, et al. Ther Ggw. 1979 Nov;118(11):1704-13. Ther Ggw. 1979. PMID: 538738 German. No abstract available.
• [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].

  Szobor A, Klein M, Bräuer H. Szobor A, et al. MMW Munch Med Wochenschr. 1982 Oct 15;124(41):897-900. MMW Munch Med Wochenschr. 1982. PMID: 6815511 Clinical Trial. German. No abstract available.
• Special therapeutical aspects of cerebrovascular disease.

  Lechner H, Ott E. Lechner H, et al. Ric Clin Lab. 1981;11 Suppl 1:247-51. Ric Clin Lab. 1981. PMID: 7188112
• [Combination of phosphatidylcholine and pentoxifylline in the therapy of progressive obstructive stroke].

  Tessitore A, Barone A. Tessitore A, et al. Acta Neurol Quad (Napoli). 1979;39:226-8. Acta Neurol Quad (Napoli). 1979. PMID: 555240 Italian. No abstract available.
• Pentoxifylline and cerebrovascular diseases.

  Marcel GA, George C. Marcel GA, et al. Eur Neurol. 1983;22 Suppl 1:89-97. doi: 10.1159/000115656. Eur Neurol. 1983. PMID: 6350013 Review.